Table 1.

All of the involved markers in esophageal cancer susceptibility among the Iranian patients

Study (et al)	Year	Gene	Purpose	Population	Results
salehi [9]	2006	eIF4E	Prognosis	99 N/Ta	Over expression
MOGHBELI [10]	2014	MSI1	Diagnosis	53 N/T	Correlation with sex
KAHKHAIE [11]	2014	MUC1	Prognosis	50 N/T	Correlation with stage, grade, and lymph node
SEDIGHI [12]	2016	MMP13	Diagnosis and Prognosis	66 patients 54 controls	Correlation with lymph node, tumor size, and survival
golyan [13]	2019	MMP21	Diagnosis and Prognosis	58 N/T	Correlation with stage
SALEHI [14]	2016	BRUCE	Diagnosis	50 N/T	Correlation with stage
ABBASZADEGAN [15]	2008	P16	Diagnosis	52 patients 50 controls	Hypermethylation
taghavi [16]	2010	P16	Diagnosis	50 N/T	Hypermethylation
ABBASZADEGAN [17]	2005	P16	Diagnosis	30 patients 30 controls	Hypermethylation
abedi-ardekani [18]	2011	P53	Diagnosis	119 patients	Mutation
khalilipour [19]	2018	KCNJ12	Diagnosis	9 patients	Mutation
forghanifard [20]	2019	DIDO1	Diagnosis	50 N/T	Correlation with depth of invasion
Ghobadi [21]	2018	CDKN2A	Prognosis	123 patients	Polymorphism was correlated with ESCC risk
hashemi-bidokhti [22]	2017	MAML1	Diagnosis and Prognosis	56 N/T	Over expression was correlated with depth of invasion, grade, stage, and sex
forghanifard [23]	2012	MAML1, TWIST1	Diagnosis and Prognosis	55 N/T	Over expressions were correlated with lymph node metastasis and stage
MOGHBELI [24]	2013	EGFR, PYGO2	Diagnosis and Prognosis	55 N/T	Correlation with stage and grade
FORGHANIFARD [25]	2014	SALL4, SOX2	Diagnosis	50 N/T	Correlation with lymph node and depth of invasion
MAHMOUDIAN [26]	2017	Cripto-1	Diagnosis	50 N/T	Correlation with tumor grade, stage, and location
MALLAK [27]	2016	EVX1	Diagnosis	50 N/T	Correlation with lymph node and depth of invasion
forghanifard [28]	2018	SIZN1	Diagnosis	50 N/T	Correlation with depth of invasion and lymph node metastasis
ANSARI [29]	2016	miR-93	Diagnosis	30 N/T	Over expression
ANSARI [29]	2016	miR-143	Diagnosis	30 N/T	Under expression
GHASEMI [30]	2018	miR-371–373	Diagnosis	36 N/T	Over expression
sahebi [31]	2016	Linc-ROR	Diagnosis	30 N/T	Correlation with grade
maghsudlu [32]	2019	miR-27a	Diagnosis and Prognosis	30 N/T	Over expression
AKBARI [33]	2008	BRCA2	Diagnosis	197 patients 254 controls	Mutation
forghanifard [34]	2011	MAGE-A4	Diagnosis and Prognosis	41 N/T	Over expression

^aTumor tissues and normal margins